Skye Bioscience, Inc. (SKYE) vs Synlogic, Inc. (SYBX)

Skye Bioscience, Inc. and Synlogic, Inc. are both Biotechnology companies. Skye Bioscience, Inc. and Synlogic, Inc. are of similar size ($7.0M and $6.7M). Across the 10 metrics below, Synlogic, Inc. leads on 9 and Skye Bioscience, Inc. on 1.

Valuation

Metric SKYE SYBX Biotechnology median
P/E n/m n/m 8.50
P/S 25.76 3.87 9.71
P/B n/m 1.03 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.16 0.64
EV/Sales 12.92 (0.24) 9.21
Earnings yield (655.48%) (6.00%) (33.15%)
Free cash flow yield (497.63%) (29.61%) (25.50%)

Profitability

Metric SKYE SYBX Biotechnology median
Gross margin 68.04% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (233.87%) (5.32%) (56.36%)
Return on assets (159.80%) (4.25%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SKYE SYBX Biotechnology median
Revenue growth (TTM) — 188.74% 6.02%
EPS growth (last fiscal year) (93.15%) 95.83% 30.26%
Revenue growth, 5-year CAGR — (67.55%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SKYE SYBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.95 9.19 4.72
Net debt to EBITDA 0.45 3.66 0.96

Dividend

Metric SKYE SYBX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SKYE SYBX Biotechnology median
Market cap 7.04m 6.68m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack